Chief Investigators

Our Chief Investigators (CIs) are highly regarded in their field, bringing world class
research expertise to the Centre

Martin Scanlon

Monash University

Professor Martin Scanlon is the Director of the ARC CFBD and Scientific Director of the Monash Fragment Platform.

Ben Capuano

Monash University

Associate Professor Ben Capuano is the Deputy Director of the ARC CFBD and leads the Fragment Elaboration theme. He is a synthetic medicinal chemist specialising in GPCRs.

Sally-Ann Poulsen

Griffith University

Professor Sally-Ann Poulsen is a medicinal chemist and leads the Fragment Screening theme.

Ray Norton

Monash University

Professor Ray Norton holds a Personal Chair at the Monash Institute of Pharmaceutical Sciences. His lab employs a range of biophysical approaches, including NMR, SPR, ITC and X-ray crystallography, in studies of peptide and protein toxins and malaria.

Michael Kassiou

University of Sydney

Professor Michael Kassiou utilises modern organic chemistry techniques to rationally design and synthesise novel compounds for a range of CNS targets.

Joel Mackay

University of Sydney

Professor Joel Mackay is a specialist in protein structure, function, design and engineering. He leads the Protein Expression & Sample Preparation theme.

Maria Halili

Griffith University

Dr Maria Halili uses a variety of techniques such as structural biology, microbiology, biochemistry and fragment-based drug discovery to develop novel antimicrobial compounds.